Neuromuscular blockade and skeletal muscle weakness in critically ill patients: time to rethink the evidence?

Explore this paper's citation graph

Summary

Evidence is provided that neuromuscular blocking agents may not be a major cause of weakness in a 21st century critical care setting and the established clinical view of an adverse relationship between the use of these agents and skeletal muscle weakness is challenged.

Type
article
Published
2012-12-14
Cited by
82
References
111

Keywords

Medicine, Neuromuscular Blockade, Critically ill, Weakness, Muscle weakness

References

Cited by

Related papers